On February 10, 2020 Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, reported that the Company will present at Noble Capital Markets’ 16th Annual Investor Conference on Monday, February 17, 2020 at 4:00 PM ET (Press release, Citius Pharmaceuticals, FEB 10, 2020, View Source [SID1234554122]). The conference is being held at the Seminole Hard Rock Hotel & Casino in Hollywood, Florida on February 16-18, 2020.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Event: Noble Capital Markets’ 16th Annual Investor Conference
Presentation Date: Monday, February 17, 2020
Presentation Time: 4:00 PM ET – Terrace Ballroom A
Location: Seminole Hard Rock Hotel & Casino – Hollywood, FL
Mr. Leonard Mazur, Chairman of Citius, will deliver an update on the Company, including a discussion of the recent positive outcome of its interim futility analysis for the Phase 3 Mino-Lok pivotal trial, and provide an overview of its other pipeline products, Mino-Wrap and Halo-Lido. Additionally, Mr. Mazur will also be available at the conference for one-on-one meetings with investors. To arrange a meeting with the Company, please contact Mr. Andrew Scott: [email protected].
Mr. Mazur’s presentation will be available for playback at the link below approximately 24 hours following his live address and be archived for 90 days following the conference: View Source
This is the 16th year Noble Capital Markets has hosted "NobleCon" and invited emerging growth companies to present to and meet with attending investors. NobleCon will feature approximately 125 small growth companies presenting across four tracks occurring simultaneously, company executives meeting with investors in 1×1/face-to-face formats, and special panel sessions featuring key opinion leaders on topics such as cannabis, biotechnology, and mining, just to name a few. Noble Capital Markets will be broadening access to investors worldwide by hosting the conference site on Channelchek.com, its web-based market platform that emphasizes emerging growth companies.